Clinical research of operation in the treatment for potentially resectable cancer of pancreatic body-tail / 天津医药
Tianjin Medical Journal
;
(12): 728-732, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-809751
ABSTRACT
@#Objective Todiscusstheclinicaleffectandtechnicalmethodofthesurgicaltreatmentforpotentially resectablecancerofpancreaticbody-tail.Methods Elevenpatientswithpotentiallyresectablecancerofpancreaticbodytailoradjacentorganmetastasis,whounderwentwideexcisionandpostoperativechemotherapyinourdepartmentwere retrospectivelyanalyzed. Results Inelevenpatients,10patientswithadjacentorganmetastasiswereperformedinvolved organsresection,3patientsweregivenresectionoftheceliacaxis(CA)andcommonhepaticartery(CHA)and2patients weregiventotalgastrectomyandjejunalinterpositionpouchreconstruction.Onepatienthadprolongedhospitalstaydueto incisioninfection,butnoseriouscomplicationsoccurredinotherpatients.Exceptfor2patients,theotherpatientsunderwent postoperativechemotherapyofgemcitabine.Allofthepatientsachievedreliefthroughoperation.Themediansurvivaltime was 28 (14, 36) months. One and 3-year survival rates were 90.9% and 36.3%. Conclusion The resection rate of potentiallyresectablecarcinomaofpancreaticbodyandtailoperationislower,andpatientshavelongbeenplaguedby abdominal pain. The treatment of extensive resection operation and recessive resection and postoperative adjuvant chemotherapycanimprovethequalityoflifeandprolongthesurvivalrateofpatients.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Tianjin Medical Journal
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS